Late‐onset Pneumocystis jirovecii pneumonia post–fludarabine, cyclophosphamide and rituximab: implications for prophylaxis

OBJECTIVE: Fludarabine, cyclophosphamide and rituximab (FCR) therapy for lymphoid malignancies has historically been associated with a low reported incidence of Pneumocystis jirovecii pneumonia (PJP). However, prophylaxis was routinely used in early studies, and molecular diagnostic tools were not e...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Haematol
Hlavní autoři: Haeusler, Gabrielle M., Slavin, Monica A., Seymour, John F., Lingaratnam, Senthil, Teh, Benjamin W., Tam, Constantine S., Thursky, Karin A., Worth, Leon J.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2013
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163499/
https://ncbi.nlm.nih.gov/pubmed/23668894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.12135
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky